Neuronal Monoclonal Antibodies Market : Rise in the Burden of Neurological Diseases to Drive the Market Growth
Monoclonal antibodies are biologic drugs that are used to treat certain types of diseases such as arthritis, neurological diseases, heart diseases, inflammatory diseases, and many more. Since their introduction, the applications of monoclonal antibodies have expanded significantly. Monoclonal antibodies are now being developed for various neurological disease such as Alzheimer's, multiple sclerosis, etc. Currently approved monoclonal antibodies for neurological conditions include natalizumab, ocrelizumab, alemtuzumab, and many more. Rise in the burden of neurological diseases with high clinical unmet needs, strong...
View full press release